Opko Health, Inc. financial data

Symbol
OPK on Nasdaq
Industry
Pharmaceutical Preparations
Location
4400 Biscayne Blvd., Miami, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
EXEGENICS INC (to 6/13/2007), eXegenics Inc (to 6/13/2007), CYTOCLONAL PHARMACEUTICS INC /DE (to 6/4/2001)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 202 % +9.52%
Quick Ratio 29.3 % -13.5%
Debt-to-equity 51.1 % +26.7%
Return On Equity -18 % -163%
Return On Assets -6.51 % +33%
Operating Margin -26.4 % -59.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 682M shares -11.7%
Entity Public Float 904M USD -14.8%
Common Stock, Value, Issued 7.12M USD -8.87%
Weighted Average Number of Shares Outstanding, Basic 695M shares -7.57%
Weighted Average Number of Shares Outstanding, Diluted 998M shares +32.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 711M USD -17.9%
Research and Development Expense 94.2M USD +4.97%
Operating Income (Loss) -188M USD -31.2%
Nonoperating Income (Expense) 70.1M USD
Income Tax Expense (Benefit) 15.9M USD +287%
Net Income (Loss) Attributable to Parent -134M USD +35.6%
Earnings Per Share, Basic -0.18 USD/shares +33.3%
Earnings Per Share, Diluted 0.03 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 400M USD +189%
Accounts Receivable, after Allowance for Credit Loss, Current 107M USD -9.26%
Inventory, Net 59.4M USD -13.9%
Other Assets, Current 9.3M USD +32.7%
Assets, Current 630M USD +76.3%
Property, Plant and Equipment, Net 66.8M USD -15.4%
Operating Lease, Right-of-Use Asset 62.8M USD +40.5%
Intangible Assets, Net (Excluding Goodwill) 641M USD -15.4%
Goodwill 536M USD -9.86%
Other Assets, Noncurrent 18.5M USD +98.3%
Assets 2.26B USD +9.7%
Accounts Payable, Current 62.7M USD -6.11%
Accrued Liabilities, Current 123M USD +33%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 212M USD +5.54%
Contract with Customer, Liability, Noncurrent 7K USD -94.9%
Deferred Income Tax Liabilities, Net 128M USD -6.95%
Operating Lease, Liability, Noncurrent 52.1M USD +50.2%
Other Liabilities, Noncurrent 36.5M USD +42.5%
Liabilities 853M USD +39.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -39.6M USD +14.8%
Retained Earnings (Accumulated Deficit) -2.08B USD -6.88%
Stockholders' Equity Attributable to Parent 1.4B USD -2.85%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.55B USD -3.91%
Liabilities and Equity 2.26B USD +9.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.6M USD -57%
Net Cash Provided by (Used in) Financing Activities 20.6M USD
Net Cash Provided by (Used in) Investing Activities -4.4M USD +43%
Common Stock, Shares Authorized 1.25B shares +25%
Common Stock, Shares, Issued 712M shares -8.88%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2M USD +52.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 420M USD +203%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.13M USD -18.4%
Deferred Tax Assets, Valuation Allowance 295M USD +5.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 282M USD +6.56%
Operating Lease, Liability 64.8M USD +41.1%
Depreciation 16.3M USD -17.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -127M USD +35.3%
Lessee, Operating Lease, Liability, to be Paid 73.8M USD +35.6%
Operating Lease, Liability, Current 12.7M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.9M USD +22.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.8M USD +6.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure -16.7%
Deferred Income Tax Expense (Benefit) -2.68M USD -2727%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.05M USD +6.04%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.8M USD +46.9%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 16.9M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.8M USD +53.3%
Operating Lease, Payments 4.33M USD +11.9%
Additional Paid in Capital 3.52B USD +2.52%
Amortization of Intangible Assets 83.8M USD -2.7%
Depreciation, Depletion and Amortization 100M USD -3.33%
Share-based Payment Arrangement, Expense 18.5M USD +36%
Interest Expense 17.8M USD +127%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%